Submissions for variant NM_000251.2(MSH2):c.1182T>G (p.Phe394Leu) (rs374135434)

Minimum review status:		Collection method:
Minimum conflict level:
		ClinVar version:

Total submissions: 7

Download table as spreadsheet

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
GeneDx	RCV000212598	SCV000149405	uncertain significance	not provided	2018-09-19	criteria provided, single submitter	clinical testing	This variant is denoted MSH2 c.1182T>G at the cDNA level, p.Phe394Leu (F394L) at the protein level, and results in the change of a Phenylalanine to a Leucine (TTT>TTG). This variant was reported in an individual with familial and/or early-onset breast cancer (Jalkh 2017). MSH2 Phe394Leu was not observed at a significant allele frequency in large population cohorts (Lek 2016). This variant is located within the Lever domain and a region of interaction with MSH6 and MSH3 (Guerrette 1998, L?tzen 2008, Kansikas 2011). In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect. Based on currently available evidence, it is unclear whether MSH2 Phe394Leu is a pathogenic or benign variant. We consider it to be a variant of uncertain significance.
Ambry Genetics	RCV000115496	SCV000184289	uncertain significance	Hereditary cancer-predisposing syndrome	2019-03-27	criteria provided, single submitter	clinical testing	Insufficient or conflicting evidence
Invitae	RCV000477595	SCV000548230	uncertain significance	Hereditary nonpolyposis colon cancer	2019-12-09	criteria provided, single submitter	clinical testing	This sequence change replaces phenylalanine with leucine at codon 394 of the MSH2 protein (p.Phe394Leu). The phenylalanine residue is highly conserved and there is a small physicochemical difference between phenylalanine and leucine. This variant is present in population databases (rs374135434, ExAC 0.003%). This variant has not been reported in the literature in individuals with MSH2-related disease. ClinVar contains an entry for this variant (Variation ID: 127627). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C15"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Color	RCV000115496	SCV000684913	uncertain significance	Hereditary cancer-predisposing syndrome	2019-12-09	criteria provided, single submitter	clinical testing
Counsyl	RCV000663103	SCV000786218	uncertain significance	Lynch syndrome I	2018-03-23	criteria provided, single submitter	clinical testing
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories	RCV000212598	SCV000884131	uncertain significance	not provided	2017-11-15	criteria provided, single submitter	clinical testing
Quest Diagnostics Nichols Institute San Juan Capistrano	RCV000212598	SCV001134330	uncertain significance	not provided	2019-04-19	criteria provided, single submitter	clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.